Published in Immunol Lett on January 01, 1985
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Altered immune responses in mice with concomitant Schistosoma mansoni and Plasmodium chabaudi infections. Infect Immun (1998) 1.57
Protection against malaria in Aotus monkeys immunized with a recombinant blood-stage antigen fused to a universal T-cell epitope: correlation of serum gamma interferon levels with protection. Infect Immun (1992) 1.45
Cellular changes and apoptosis in the spleens and peripheral blood of mice infected with blood-stage Plasmodium chabaudi chabaudi AS. Infect Immun (2000) 1.41
Tumor necrosis factor production by human sarcoid alveolar macrophages. Am J Pathol (1986) 1.37
Tumor necrosis factor does not induce Plasmodium falciparum crisis forms. Infect Immun (1987) 0.90
Phagocyte-derived reactive oxygen species do not influence the progression of murine blood-stage malaria infections. Infect Immun (2005) 0.88
Immunization of mice against blood-stage Plasmodium yoelii malaria with isoelectrically focused antigens and correlation of immunity with T-cell priming in vivo. Infect Immun (1988) 0.86
T-cell recognition of a cross-reactive antigen(s) in erythrocyte stages of Plasmodium falciparum and Plasmodium yoelii: inhibition of parasitemia by this antigen(s). Infect Immun (1993) 0.75
The cellular basis of immunological responses. A synthesis of some current views. Lancet (1969) 6.05
Human cytolytic and interferon gamma-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (1998) 3.59
Focal antibody production by transferred spleen cells in irradiated mice. Science (1965) 3.12
Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumour necrosis factor from human and murine macrophages. Clin Exp Immunol (1989) 3.09
Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98
The role of gamma-interferon, vitamin D3 metabolites and tumour necrosis factor in the pathogenesis of tuberculosis. Immunology (1987) 2.91
Interactions of TRIC agents with macrophages and BHK-21 cells observed by electron microscopy. J Hyg (Lond) (1973) 2.85
Cultivation of TRIC agents: a comparison between the use of BHK-21 and irradiated McCoy cells. J Hyg (Lond) (1974) 2.66
Immunosuppression in murine malaria. I. General characteristics. Clin Exp Immunol (1971) 2.56
Malarial parasites induce TNF production by macrophages. Immunology (1988) 2.42
Malarial parasites and tumour cells are killed by the same component of tumour necrosis serum. Clin Exp Immunol (1984) 2.34
Endotoxin-induced serum factor kills malarial parasites in vitro. Infect Immun (1981) 2.30
Inherited interleukin 12 deficiency in a child with bacille Calmette-Guérin and Salmonella enteritidis disseminated infection. J Clin Invest (1998) 2.30
Induction of red cell autoantibodies in normal mice. Nat New Biol (1973) 2.09
Malaria: phosphatidylserine expression is not increased on the surface of parasitized erythrocytes. Parasitol Today (1995) 2.05
Protection of mice against malaria by a killed vaccine: differences in effectiveness against P. yoelii and P. berghei. Immunology (1977) 2.03
Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02
Cell cooperation in the immune response. Clin Exp Immunol (1971) 1.91
Cell-mediated immunity in mice vaccinated against malaria. Clin Exp Immunol (1978) 1.82
Differential sensitivity in vivo of lethal and nonlethal malarial parasites to endotoxin-induced serum factor. Infect Immun (1982) 1.79
Suppressor T cells in experimental autoimmune haemolytic anaemia. Nature (1978) 1.79
Separate thymus dependent and thymus independent antibody forming cell precursors. Nat New Biol (1971) 1.78
Tumour necrosis factor induction by malaria exoantigens depends upon phospholipid. Immunology (1992) 1.78
Soluble malarial antigens are toxic and induce the production of tumour necrosis factor in vivo. Immunology (1989) 1.77
Killing of human malaria parasites by macrophage secretory products. Infect Immun (1984) 1.76
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria. Infect Immun (1997) 1.75
Killing of blood-stage murine malaria parasites by hydrogen peroxide. Infect Immun (1983) 1.74
The malaria vaccine: anti-parasite or anti-disease? Immunol Today (1990) 1.74
The role of antibody in T-cell responses. Clin Exp Immunol (1974) 1.67
The role of the liver in immunity to blood-stage murine malaria. Immunology (1980) 1.65
Cell-mediated immunity in the liver of mice vaccinated against malaria. Nature (1979) 1.64
Strain differences in the behavior of TRIC agnets in cell cultures. Am J Ophthalmol (1967) 1.62
Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro. Clin Exp Immunol (1987) 1.62
Rosette formation by mouse lymphocytes. III. Receptors for immunoglobulin on normal and activated T cells. Clin Exp Immunol (1974) 1.59
Strain differences in the immune responses of mice. 3. A raised tolerance threshold in NZB thymus cells. Immunology (1971) 1.57
Specific tolerance to sheep erythrocytes in mouse bone marrow cells. Nature (1969) 1.52
Expression and rescuing of a cloned human tumour necrosis factor gene using an EBV-based shuttle cosmid vector. EMBO J (1987) 1.48
Response of mouse T and B lymphocytes to sheep erythrocytes. Nat New Biol (1972) 1.45
Strain differences in the immune response of mice. II. Responses by neonatal cells in irradiated adult hosts. Immunology (1968) 1.45
Interactions of TRIC agents with macrophages: effects on lysosomal enzymes of the cell. J Hyg (Lond) (1974) 1.43
Recombinant gamma interferon is a potent adjuvant for a malaria vaccine in mice. Clin Exp Immunol (1987) 1.42
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Human and murine macrophages produce TNF in response to soluble antigens of Plasmodium falciparum. Parasite Immunol (1990) 1.40
Rosette formation by mouse lymphocytes. II. T-cell specificities in a CRL subpopulation. Clin Exp Immunol (1974) 1.39
Indirect immunofluorescence of mouse thymus-derived cells using heterologous anti-brain serum. Cell Immunol (1973) 1.38
Reactivity and crossreactivity of mouse helper T cells to malaria parasites. Immunology (1977) 1.36
Some consequences of the multiple infection of cell cultures by TRIC organisms. J Hyg (Lond) (1972) 1.36
Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Immunology (1990) 1.35
Killing of the malarial parasite Plasmodium yoelii in vitro by cells of myeloid origin. Parasite Immunol (1982) 1.34
Immunity to malaria. Br Med Bull (1982) 1.34
Antibody responses in mice protected against malaria by vaccination. Parasite Immunol (1979) 1.34
Antibody formation by bone marrow cells in irradiated mice. I. Thymus-dependent and thymus-independent responses to sheep erythrocytes. Immunology (1971) 1.31
Neutralization of TRIC organisms by antibody: enhancement by antisera prepared against immunoglobulins. J Hyg (Lond) (1974) 1.31
Syngeneic splenomegaly in NZB and BALB-c mice. Transplantation (1969) 1.30
Spontaneously arising cytotoxicity to the P-815-Y mastocytoma in NZB mice. Clin Exp Immunol (1974) 1.27
The genetic basis of autoimmunity in NZB mice studied by progeny-testing. Clin Exp Immunol (1971) 1.24
Antibodies against phosphatidylinositol and inositol monophosphate specifically inhibit tumour necrosis factor induction by malaria exoantigens. Immunology (1992) 1.23
Two soluble antigens of Plasmodium falciparum induce tumor necrosis factor release from macrophages. Infect Immun (1990) 1.21
Vaccination of mice against malaria with soluble antigens. I. The effect of detergent, route of injection, and adjuvant. Parasite Immunol (1986) 1.20
Anaemia and resistance to malaria in transgenic mice expressing human tumour necrosis factor. Immunology (1994) 1.19
Rosette formation by mouse lymphocytes. I. Demonstration by indirect immunofluorescence of T cells binding sheep erythrocytes. Clin Exp Immunol (1974) 1.17
Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature (1983) 1.15
Two distinct types of non-specific immunosuppression in murine malaria. Clin Exp Immunol (1980) 1.14
Stimulation and suppression of response of mouse T cells to the schistosomules of Schistosoma mansoni during infection. Nature (1976) 1.14
Serum IL-2 inhibitor in mice. I. Increase during infection. Immunology (1985) 1.14
B cells: subpopulations, tolerance, autoimmunity, and infection. Immunol Rev (1979) 1.13
Age-dependent changes in the relative affinity of anti-dinitrophenyl antibodies in mice. Immunology (1975) 1.13
Lymphocyte traffic and lymphocyte destruction in murine malaria. Immunology (1982) 1.13
Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination. Clin Exp Immunol (1986) 1.12
Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity. Clin Exp Immunol (1985) 1.12
Differential involvement of non-specific suppressor T cells in two lethal murine malaria infections. Clin Exp Immunol (1981) 1.11
Detoxified exoantigens and phosphatidylinositol derivatives inhibit tumor necrosis factor induction by malarial exoantigens. Infect Immun (1992) 1.10
Killing of Plasmodium yoelii by enzyme-induced products of the oxidative burst. Infect Immun (1984) 1.10
Malaria toxins: hypoglycaemia and TNF production are induced by different components. Parasitol Today (1995) 1.10
Malaria exoantigens induce TNF, are toxic and are blocked by T-independent antibody. Immunol Lett (1990) 1.09
Malaria toxins: TNF-mediated phenomena. Parasitol Today (1996) 1.09
Changes in the capacity of macrophages and T cells to produce interleukins during murine malaria infection. Cell Immunol (1984) 1.06
Endotoxin induced 'tumour-necrosis serum' kills a subpopulation of normal lymphocytes in vitro. Clin Exp Immunol (1982) 1.05
Differential gene expression of activating Fcγ receptor classifies active tuberculosis regardless of human immunodeficiency virus status or ethnicity. Clin Microbiol Infect (2013) 1.04
Anti-lymphocyte antibodies in lethal mouse malaria. II. Induction of an autoantibody specific suppressor T cell by non-lethal P. yoelii. Clin Exp Immunol (1983) 1.04
A comparison of eosinophil-activating factor (EAF) with other monokines and lymphokines. Eur J Immunol (1986) 1.03
Cooperation by mouse T lymphocytes: the role of antibody in T cell specificity. Eur J Immunol (1974) 1.03
Failure of malaria vaccination in mice born to immune mothers. Clin Exp Immunol (1982) 1.03